Literature DB >> 1610719

Behavioral performance effects of verapamil in normotensive and renovascular hypertensive baboons.

J S Turkkan1, R D Hienz.   

Abstract

Behavioral performances of normotensive and hypertensive adult male baboons were tested before, during, and following chronic oral dosing with verapamil. Performances during a five-color simultaneous match-to-sample task were measured for two doses (2.0, and 3.2 mg/kg/day) and vehicle. Each dose was administered for 21 consecutive days preceded and followed by 14-day baseline and recovery periods, respectively. Choice reaction times increased by 9% during the lower dose of verapamil, compared to vehicle; choice reaction times were unchanged at the higher dose. At baseline and during vehicle administration, the yellow and white stimuli were the most difficult to discriminate correctly; discrimination of these colors was slightly impaired by the lower, but not the higher dose of verapamil. Verapamil's behavioral effects were not modulated by blood pressure changes since both baboon groups showed equivalent changes in behavioral performance, but only renovascular hypertensive baboons showed blood pressure decreases. Verapamil appears to be an effective hypotensive and does not produce profound psychomotor impairment at clinically used doses during the first weeks of treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1610719     DOI: 10.1007/bf02698503

Source DB:  PubMed          Journal:  Integr Physiol Behav Sci        ISSN: 1053-881X


  28 in total

1.  Inter- and intra-subject variation in the first-pass elimination of highly cleared drugs during chronic dosing. Studies with deuterated verapamil.

Authors:  M Eichelbaum; A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

2.  Verapamil and myoclonic dystonia.

Authors:  C B Hicks; K Abraham
Journal:  Ann Intern Med       Date:  1985-07       Impact factor: 25.391

3.  Behavioral effects of chronic, orally administered diuretic and verapamil in baboons.

Authors:  J S Turkkan; R D Hienz
Journal:  Pharmacol Biochem Behav       Date:  1991-01       Impact factor: 3.533

4.  Calcium antagonist binding sites in the rat brain: quantitative autoradiographic mapping using the 1,4-dihydropyridines [3H]PN 200-110 and [3H]PY 108-068.

Authors:  R Cortés; P Supavilai; M Karobath; J M Palacios
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

5.  Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Black Hypertension Quality of Life Multicenter Trial Group.

Authors:  S H Croog; B W Kong; S Levine; M R Weir; R M Baume; E Saunders
Journal:  Arch Intern Med       Date:  1990-08

6.  Effects of two forms of hypertension on atherosclerosis in the hyperlipidemic baboon.

Authors:  H C McGill; K D Carey; C A McMahan; Y N Marinez; T E Cooper; G E Mott; C J Schwartz
Journal:  Arteriosclerosis       Date:  1985 Sep-Oct

7.  Effects of calcium antagonists on phencyclidine behaviors.

Authors:  G T Bolger; M F Rafferty; J N Crawley; S M Paul; P Skolnick
Journal:  Pharmacol Biochem Behav       Date:  1986-07       Impact factor: 3.533

8.  Pure tone thresholds in the yellow baboon (Papio cynocephalus).

Authors:  R D Hienz; J S Turkkan; A H Harris
Journal:  Hear Res       Date:  1982-09       Impact factor: 3.208

9.  Species of the genus Papio (Cercopithecidae, primates) as subjects of biomedical research: II. Quantitative characteristics of contemporary use of baboon species in medical and biological investigations.

Authors:  E P Fridman; V N Popova
Journal:  J Med Primatol       Date:  1988       Impact factor: 0.667

10.  Operant methodology in the study of learning.

Authors:  D M Thompson; J M Moerschbaecher
Journal:  Environ Health Perspect       Date:  1978-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.